$NVS Not a poster on this tab but wanted to share that today, received $2 value rights from Novartis' acquisition of Chinook Therapeutics ($KDNY) arising from the approval of Atrasentan. There are $2 more in milestones to go as commercialiation develops.
…good example of why hiring / firing decisions can be noise in predicting outcomes for an outside investor. Because $PLRX Pliant was on a major hiring push just a month ago.
Including hiring the CTO Dr Imbert after a very successful sale of $KDNY Chinook to NVS .
~ In May 2023, Muddy Waters accused #
Chinook and AbbVie of manipulating trial results for lead product candidate.
~ $KDNY fell 7%, losing $100M+ shareholder value.
~ Investors may suspect $KDNY of unlawful biz practices, which led to their losses => https://11thestate.com/cases/chinook-investor-case
$KDNY Had some short $40 $KDNY calls called away right before the deal closed. So as of today, I am short about 1500 shares at ~$40.73 (strike plus premium). I know that my account will be debited $40 per share because of the $40 per cash offer. But what happens to the CVRs? Will a CVR security be issued? Will it trade on an exchange? I will be short that security and will be looking to close out my position.
How do thinks proceed from here?
@BeaconABB Short term damage from capital raise to complete Ph3 activities. But they know owning a big winner for long term, with future partnerships or even potential buyout. I own $KDNY and got 6x gain from recent buyout by $NVS. Just my opinion and not financial advice. Do your own DD and place your bet GL
$CMCSA, $KDNY and $ANF are making a new 52 week high.
https://www.chartmill.com/stock/stock-screener?f=p_pg10,v1_50b500,s_nh,exch_us&v=3&utm_source=New_52_week_high_today&utm_medium=stocktwits&utm_campaign=screen
@OB1OB2 I'm a pro and don't often lose! LOL Still have plenty of gain from $KDNY being bought out. Bring on this Thursday 8/10 corporate update, then I shall hit another homerun this year with $VTGN? Got to love the science that can help 25M Americans? 🚀🚀
$VTGN My first home run was with $KDNY after buyout offer by $NVS this year, and now just picked up 5,000 shares of VistaGen avg ~$13 today. Very positive topline Ph3 results! Target $30+ this week and better days ahead! GLTA
$AUPH Jefferies:" $AUPH CC Thursday 8.30am; 2Q est of $39M (vs $37.4M cons) for Lupkinis; reasonable acquisition value could be ~2.5-3.5X, referencing historical avg, recent $KDNY acquisition, and assuming some discount for IP risk. We est $AUPH peak sales $600M WW in 2027."
$KDNY was analyzed by 17 analysts. The buy consensus is at 74%. So analysts seem to be mildly confident about $KDNY. https://www.chartmill.com/stock/quote/KDNY/analyst-ratings?utm_source=stocktwits&utm_medium=ANALYST&utm_content=KDNY&utm_campaign=social_tracking
